CAH · NYSE
Cardinal Health (CAH) Stock Price & Fundamentals
Cardinal Health (CAH) closed at $232.45 on Oct 9, 2026, up 0.88% from the previous close of $230.43.
Share price, past year
1Y +28.23%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $232.45 |
| Sep 30, 2026 | $230.74 |
| Aug 31, 2026 | $251.59 |
| Jul 31, 2026 | $243.34 |
| Jun 30, 2026 | $223.60 |
| May 29, 2026 | $228.38 |
| Apr 30, 2026 | $225.69 |
| Mar 31, 2026 | $226.60 |
| Feb 27, 2026 | $202.26 |
| Jan 30, 2026 | $205.07 |
| Dec 31, 2025 | $203.23 |
| Nov 28, 2025 | $194.19 |
| Oct 31, 2025 | $190.94 |
Key statistics
- Market cap
- $54.06B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $244.67B
- Net income (TTM)
- $1.66B
- Shares outstanding
- 232.6M
- Dividend yield
- —
- 52-week range
- $181.28 – $257.51
Cardinal Health's market cap is $54.06B, based on a share price of $232.45 and 232.6M shares outstanding as of Jul 31, 2026.
Financials
Cardinal Health reported revenue of $254.25B for fiscal 2026, up 14.23% from fiscal 2025.
Cardinal Health earned net income of $1.71B in fiscal 2026, a net margin of 0.7%.
Fiscal 2026 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $254.25B | +14.2% | $1.71B | 0.7% | $7.23 | $4.53B |
| FY2025ended Jun 30, 2025 | $222.58B | −1.9% | $1.56B | 0.7% | $6.45 | $1.85B |
| FY2024ended Jun 30, 2024 | $226.83B | +10.7% | $852.00M | 0.4% | $3.45 | $3.25B |
| FY2023ended Jun 30, 2023 | $204.98B | +13.0% | $330.00M | 0.2% | $1.26 | $2.36B |
| FY2022ended Jun 30, 2022 | $181.33B | +11.6% | −$938.00M | −0.5% | −$3.37 | $2.79B |
| FY2021ended Jun 30, 2021 | $162.47B | +6.2% | $611.00M | 0.4% | $2.08 | $2.03B |
| FY2020ended Jun 30, 2020 | $152.92B | +5.1% | −$3.70B | −2.4% | −$12.61 | $1.59B |
| FY2019ended Jun 30, 2019 | $145.53B | +6.4% | $1.36B | 0.9% | $4.53 | $2.39B |
| FY2018ended Jun 30, 2018 | $136.81B | +5.3% | $256.00M | 0.2% | $0.81 | $2.38B |
| FY2017ended Jun 30, 2017 | $129.98B | — | $1.29B | 1.0% | $4.03 | $797.00M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Dec 31, 2025 | $65.63B | $467.00M | — |
| Q1 FY2026ended Sep 30, 2025 | $64.01B | $450.00M | $1.88 |
| Q4 FY2025ended Jun 30, 2025 | $60.16B | $239.00M | — |
| Q3 FY2025ended Mar 31, 2025 | $54.88B | $506.00M | — |
| Q2 FY2025ended Dec 31, 2024 | $55.26B | $400.00M | — |
| Q1 FY2025ended Sep 30, 2024 | $52.28B | $416.00M | $1.70 |
| Q4 FY2024ended Jun 30, 2024 | $59.87B | $235.00M | $0.93 |
| Q3 FY2024ended Mar 31, 2024 | $54.87B | $261.00M | $1.07 |
Company profile
- Name
- Cardinal Health, Inc.
- Ticker
- CAH
- Exchange
- NYSE
- Industry (SEC SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- 7000 Cardinal Place, Dublin, OH 43017
- Incorporated in
- OH
- Fiscal year ends
- June
- SEC CIK
- 0000721371
Recent SEC filings
- Oct 1, 2026
- Aug 11, 2026
- Aug 11, 2026
- Aug 11, 2026
- Aug 5, 2026
- Apr 30, 2026
- Apr 30, 2026
- Mar 23, 2026
Frequently asked questions
What is Cardinal Health's stock price?
Cardinal Health (CAH) closed at $232.45 on Oct 9, 2026, up 0.88% from the previous close of $230.43.
What is Cardinal Health's market cap?
Cardinal Health's market cap is $54.06B, based on a share price of $232.45 and 232.6M shares outstanding as of Jul 31, 2026.
How much revenue does Cardinal Health make?
Cardinal Health reported revenue of $254.25B for fiscal 2026, up 14.23% from fiscal 2025.
Does Cardinal Health pay a dividend?
Cardinal Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cardinal Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures